Xenetic Biosciences appoints James F. Parslow as CFO
Xenetic Biosciences, a clinical-stage biopharmaceutical company, announced that it has appointed James F. Parslow as chief financial officer.Mr. Parslow is a seasoned financial executive with over 25 years of experience providing financial and business leadership to the manufacturing, technology, business-to-business e-commerce and clean tech industries.
READ MORE Xenetic Biosciences appoints director
Prior to joining Xenetic, Mr. Parslow most recently served as Chief Financial Officer, Treasurer and Secretary of World Energy Solutions, Inc., a publicly-traded business-to-business e-commerce company brokering energy and environmental commodities, from 2006 until the company was acquired by EnerNOC, Inc. in 2015.
From 2004 to 2006, Mr. Parslow served as Chief Financial Officer of Spire Corporation. ■
What to read next
LATEST MOVES FROM Massachusetts
- Chiasma re-appoints Roni Mamluk to board
- BayCoast Bank appoints James Wallace as CFO
- Pulmatrix appoints Amit D. Munshi to board
- Syros Pharmaceuticals appoints Srinivas Akkaraju to board
- Merrimack Pharma names Sergio Santillana as CMO
More inside POST
